TAFP Webinar - Alzheimer's Disease

TAFP Webinar: Family Physicians and Early Detection of Cognitive Impairment and Alzheimer’s Disease

1 AMA PRA Category 1 Credit™, 1 AAFP Prescribed Credit, and an ethics credit; available through 7/20/2021.

Scroll down for the link to watch the video. You will be asked to enter your full name and email address before the video starts. At the conclusion of the video you’ll see a link for the CME evaluation survey and a certificate will be emailed to you within a week. If you have problems with the video or trouble accessing the evaluation, please contact Jessica Miley at jmiley@tafp.org.




Objectives

  • Recognize signs and symptoms suggestive of cognitive impairment and Alzheimer’s disease.
  • Discuss the benefits of early detection and diagnosis of Alzheimer’s disease.
  • Evaluate some key ethical issues in the early detection of Alzheimer’s disease and in communicating the diagnosis of Alzheimer’s disease to patients and their families.
  • Learn about the resources available to help your practice care for people with cognitive impairment and Alzheimer’s disease, including formulating comprehensive care plans.

Faculty
Mary Quiceno, MD
Behavioral Neurologist
Adjunct Associate Professor, Department of Geriatrics
University of North Texas Health Science Center
Fort Worth, Texas

Moderator
Brittany Love, DO
Assistant Professor, Department of Geriatrics
University of North Texas Health Science Center
Fort Worth, Texas

Faculty disclosures
Dr. Quiceno has disclosed that she is a contractor for the NFL Concussion Settlement Appeals Advisory Panel, she is the Medical Director of Parexel International, and she is on the board for the Alzheimer’s Association Stomping Ground Theater. Dr. Quiceno has disclosed that she will discuss information that is related to an off-label or investigational use of therapy, product or device in this educational activity.

Planner and moderator disclosures
All staff, planners (Jessica Miley of TAFP), (Laura McEntire and Kathy Shockley of the Alzheimer’s Association) and moderator (Brittany Love, DO, of UNT) involved in this activity have disclosed that neither they nor their family members have any actual or potential conflict of interest.

Supporter disclosure
This educational activity is supported by an educational grant from UNT Health Science Center. It has been planned and produced by the Alzheimer’s Association with the Texas Academy of Family Physicians strictly as an accredited continuing medical education activity.

This project is supported by the HSC WE HAIL Program and Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U1QHP28735. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the Health Resources and Services Administration or the U.S. Department of Health and Human Services.

Accreditation statements
This enduring internet activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education through the joint providership of the Texas Academy of Family Physicians and Alzheimer’s Association. The Texas Academy of Family Physicians is accredited by the ACCME to provide continuing medical education for physicians. Texas Academy of Family Physicians designates this internet enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This course has been designated by the TAFP for up to 1 hour of credit in ethics and/or professional responsibility.

This enduring internet activity, Family Physicians and Early Detection of Cognitive Impairment and Alzheimer’s Disease, with a beginning date of July 20, 2020, has been reviewed and is acceptable for up to 1 Prescribed Credit by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Cost of activity
There are no fees required for participating in or receiving credit for this online enduring CME educational activity.

Contact information
Texas Academy of Family Physicians
Jessica Miley, CHCP, Director of CME and Compliance
12012 Technology Blvd., Suite 200, Austin, TX 78727
Phone: (512) 329-8666
Fax: (512) 329-8237
Email: jmiley@tafp.org
Website: www.tafp.org

Watch Webinar →

Additional information

Target audience
This activity is intended to meet the educational needs of family physicians and other primary care clinicians including internists, nurse practitioners, and physician assistants who are seeking additional education in the assessment, diagnosis, and ongoing health care of patients with cognitive impairment and dementia.

Participation instructions
This activity is designed to be completed within the time designated on the main page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the main page. To receive AMA PRA Category 1 Credit™ and/or AAFP Prescribed Credit, you must complete the CME evaluation survey. Your full name, designation and email address must be completed within the CME evaluation survey.

In order to receive CME credits you must read the learning objectives, faculty and planner disclosures, supporter disclosure, target audience, and accreditation statements. You must watch the webinar in its entirety including the Q&A session. Opportunities for additional questions for the faculty will be provided in the CME evaluation survey. The survey link will be provided at the end of the webinar.

CME certificates will emailed to you within 7 days of completion of the enduring activity. Please contact Jessica Miley at jmiley@tafp.org if you have any questions about the activity or CME credit.

Bibliography

  1. www.alz.org
  2. CDR – https://knightadrc.wustl.edu/cdr/PDFs/CDR_Table.pdf
  3. SCD-Q, Journal of Alzheimer’s Disease, 41 (2014) 453-466.
  4. M@T, Int J Geriatr Psychiatry,2007; 22: 294–304.
  5. Passler JS, Kennedy RE, Clay OJ, Crowe M, Howard VJ, Cushman M, Unverzagt FW, Wadley VG. (2020) The relationship of longitudinal cognitive change to self-reported IADL in a general population. Aging, Neuropsychology, and Cognition, 27:1, 125-139.
  6. Degener. AD Why We Need Early Diagnosis, Neurol Neuromuscul Dis. 2019; 9: 123–130.
  7. Dementia prevention, intervention, and care. The Lancet, Vol. 390, No. 10113.
  8. https://alz.org/professionals/health-systems-clinicians/guidelines_index_(1)

Disclaimer
All materials are included with permission from all parties. The opinions expressed are those of the faculty and are not to be construed as those of the Texas Academy of Family Physicians, Alzheimer’s Association, or moderator.

This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

This CME activity will describe the off-label, investigational, or experimental use of medications that may exceed their FDA- approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products.

Copyright statement
Texas Academy of Family Physicians, 12012 Technology Blvd., Suite 200, Austin, TX 78727
Texas Academy of Family Physicians is a not-for-profit 501(c)(6) organization.
© 2020 Texas Academy of Family Physicians®. All rights reserved.